A	B	C	D	E	F	G	H	I	J	K	L	M	N	O	P
1	Main
2		CEO: Joaquin Duato replaced Alex Gorsky.
3		CFO: Joseph Wolk replaced Dominick Caruso who retired
4
5		Pharmaceuticals - 41% of sales in 2007, 30.8% operating margin, 49% of operating profits.
6		Jennifer Taubert, Chairman
7		Sheri McCoy, who left for AVP, replaced Chris Poon who retired in March 2008 (came from BMY in 2000?).
8		Organized into Centocor/OBI, Jannsen?, Scios, Ortho-Biologics? Tibotec, Cilag
9		Jaime Oliver, Therapeutic Area Lead, Immunology, EMEA
10		Craig Tendler, Global Head of Late Development, Diagnostics & Medical Affairs, HemOnc
11		Edmond Chan, EMEA Hematology therapeutic lead
12
13		MD&D - Ashley McEvoy. Alex Gorsky was WW head. Former head Nicholas Valeriani (35% of sales in 2007, 27.4% operating margin, 37% of operating profits, $270bn global market).
14		Split into Surgical Care group and Comprehensive Care group.
15		Surgical Care - DePuy, Ethicon, Ethicon-EndoSurgery - Alex Gorsky is WW Chairman (Was JNJ, NVS). Sheri McCoy was WW Chairman.
16		Comprehensive Care - Cordis, Diabetes Care, Vision Care, Ortho Clinical Diagnostics - Donald Casey is WW Chairman.
17		Ortho Clinical Diagnostics - Nicholas Valeriani.
18		Vision - Michael Sneed.
19		Diabetes - Michael Paul.
20		Consumer - Thibaut Mongon. Colleen Goggins is WW Chairman. (24% of sales in 2007, 15.8% operating margin, 15% of operating profits).
21		OTC/Nutritions is largest business unit. Marc Robinson is Group Chairman.
22		McNeil Consumer Healthcare, McNEIL-PPC.
23
24		Nicholas Valeriani - Formerly VP, Office of Strategy and Growth, Member of Executive Committee. Now OCD Chairman.
25		Louise Mehrotra - VP IR - Retired
26
27		Robert Zivin
28		Centocor - Kim Taylor - CEO
29		Tibotec
30		Cordis - Seth Fischer - Company Group Chairman
31		William N. Hait, M.D., Ph.D., Global Therapeutic Area Head, Oncology, for Johnson & Johnson Pharmaceutical Research & Development, L.L.C., an affiliate of Ortho-McNeil Janssen
32		Martin Fitchet, M.D., Global Therapeutic Area Head, Cardiovascular & Metabolism, for OMJPI affiliate, Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
33		Husseini K. Manji, Global Therapeutic Area Head, Neuroscience, Johnson & Johnson Pharmaceutical Research & Development
34		Campbell Rogers, M.D., Chief Scientific Officer and Global Head, Research and Development, Cordis Corporation.
35
36		JJDC								COST						CD/BD
37		Brad Vale - Head of Venture Investments - Former COST and Ethicon.								Robert Zivin, PhD						Jens Bitsch-Norhave
38		Joel Krikston - Venture Investments - Former BD/CD														Marina Tarasova
39		Asish Xavier - Venture Investments VP - Former BioRexis														Miriam Rogers
40		Michael Chuisano - Venture Investments VP - Former CD/BD														Deb Masone
41		Renee Ryan - Venture Investments VP - Former RW Baird Banker														Suzanne Cross
42		Zeev Zehavi - Venture Investments VP - Former Teva														Nick D'Aleandro
43		Jun Wu - Venture Investments Principal - Former Ethicon														Tao Fu - Head of M&A
44		Dalton Einhorn - Venture Investments Principal - Former Latterell Ventures														Scott Lundeen
45		Kadir Kadhiresan - Venture Investments Principal - Former Guidant														Julie Scheffler
46		Rami Elghandour - Venture Investments Principal - Former ANS														Greg Fersko
47																Mike Fox
48																Vanitha Sekar
49
50
51		Departed
52		William Weldon	CEO, Retired
53		Alex Gorsky	CEO, Retired
54		Paul Stoffels	former Global Head of R&D